Buprenorphine Dose Alteration Study - 1
Phase 1
Completed
- Conditions
- Opioid-Related Disorders
- Registration Number
- NCT00000219
- Lead Sponsor
- University of Vermont
- Brief Summary
The purpose of this study is to examine the effects in buprenorphine dose alterations in opioid dependent individuals being maintained on buprenorphine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Physiological changes in: pupil diameter Subjective dose estimate Physiological changes in: blood pressure Physiological changes in: respiration Physiological changes in: heart rate Opioid withdrawal Drug effect characteristics: ARCI Physiological changes in: skin temperature
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Treatment Research Center
🇺🇸Burlington, Vermont, United States